Apetroaei M, Velescu B, Nedea M, Dinu-Pirvu C, Draganescu D, Faca A
Biomedicines. 2024; 12(4).
PMID: 38672269
PMC: 11048092.
DOI: 10.3390/biomedicines12040915.
Wang C, Yu X, Ke Y, Fu Y, Luo Y, Li Y
Antimicrob Agents Chemother. 2024; 68(4):e0166823.
PMID: 38483175
PMC: 10989015.
DOI: 10.1128/aac.01668-23.
Fimbo A, Mwalwisi Y, Mwamwitwa K, Matiko D, Mfinanga E, Lyimo J
Sci Rep. 2024; 14(1):615.
PMID: 38182720
PMC: 10770041.
DOI: 10.1038/s41598-023-51144-7.
Li J, Agbobli-Nuwoaty S, Palella F, Novak R, Tedaldi E, Mayer C
AIDS Res Treat. 2023; 2023:4423132.
PMID: 38078054
PMC: 10703529.
DOI: 10.1155/2023/4423132.
Tatsing Foka F, Tumelo Mufhandu H
Viruses. 2023; 15(8).
PMID: 37632074
PMC: 10458198.
DOI: 10.3390/v15081732.
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao A, Crutchley R, Guduru R, Ton K, Lam T, Min A
Retrovirology. 2022; 19(1):22.
PMID: 36273165
PMC: 9588231.
DOI: 10.1186/s12977-022-00608-1.
Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting.
Mete B, Gunduz A, Kumbasar Karaosmanoglu H, Gumuser F, Bolukcu S, Yildiz D
Afr Health Sci. 2022; 21(4):1593-1602.
PMID: 35283956
PMC: 8889812.
DOI: 10.4314/ahs.v21i4.13.
Summary of 2021 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans.
Infect Chemother. 2021; 53(3):592-616.
PMID: 34405598
PMC: 8511382.
DOI: 10.3947/ic.2021.0305.
Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART.
Kanters S, Karim M, Thorlund K, Anis A, Zoratti M, Bansback N
BMC Med Res Methodol. 2021; 21(1):60.
PMID: 33784981
PMC: 8008675.
DOI: 10.1186/s12874-021-01254-5.
Update on Adverse Effects of HIV Integrase Inhibitors.
Kolakowska A, Freire Maresca A, Collins I, Cailhol J
Curr Treat Options Infect Dis. 2020; 11(4):372-387.
PMID: 33380904
PMC: 7758219.
DOI: 10.1007/s40506-019-00203-7.
HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.
Scarsi K, Havens J, Podany A, Avedissian S, Fletcher C
Drugs. 2020; 80(16):1649-1676.
PMID: 32860583
PMC: 7572875.
DOI: 10.1007/s40265-020-01379-9.
Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada.
Lu H, Cole S, Westreich D, Hudgens M, Adimora A, Althoff K
Clin Infect Dis. 2020; 73(7):e1408-e1414.
PMID: 32780095
PMC: 8492356.
DOI: 10.1093/cid/ciaa1037.
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Mills A, Brunet L, Fusco J, Wohlfeiler M, Garris C, Oglesby A
Infect Dis Ther. 2019; 9(1):41-52.
PMID: 31701370
PMC: 7054577.
DOI: 10.1007/s40121-019-00274-5.
Recent Trends and Effectiveness of Antiretroviral Regimens Among Men Who Have Sex With Men Living With HIV in the United States: The Multicenter AIDS Cohort Study (MACS) 2008-2017.
Li X, Brown T, Ho K, Witt M, Phair J, Jacobson L
Open Forum Infect Dis. 2019; 6(9):ofz333.
PMID: 31660409
PMC: 6798255.
DOI: 10.1093/ofid/ofz333.
Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings.
Nance R, Vannappagari V, Smith K, Johannes C, Calingaert B, Saltus C
J Acquir Immune Defic Syndr. 2019; 81(5):572-577.
PMID: 31107299
PMC: 6649666.
DOI: 10.1097/QAI.0000000000002075.
The 2018 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.
Infect Chemother. 2019; 51(1):77-88.
PMID: 30941943
PMC: 6446007.
DOI: 10.3947/ic.2019.51.1.77.
Single-Tablet Regimens in the Treatment of HIV-1 Infection.
Cutrell J, Bedimo R
Fed Pract. 2019; 33(Suppl 3):24S-30S.
PMID: 30766212
PMC: 6375416.
HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study.
Murrell D, Cluck D, Moorman J, Brown S, Wang K, Duffourc M
Clin Drug Investig. 2019; 39(3):285-299.
PMID: 30623371
DOI: 10.1007/s40261-018-0739-9.
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide.
Alvarez H, Marino A, Valcarce N, Garcia-Gonzalez J, Diaz-Cambre H, Llibre J
Infection. 2018; 47(1):115-119.
PMID: 30145772
DOI: 10.1007/s15010-018-1201-x.
HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
Nance R, Delaney J, Simoni J, Wilson I, Mayer K, Whitney B
Ann Intern Med. 2018; 169(6):376-384.
PMID: 30140916
PMC: 6388406.
DOI: 10.7326/M17-2242.
